Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating ultrasound and biomarkers for monitoring abdominal aortic aneurysm after repair

Official title: Comparación De La Eficacia Entre Biomarcadores Y Ecografía Con Contraste Frente a Angio-TC En El Seguimiento De Aneurismas De Aorta Abdominal (AAA) Tras Reparación Endovascular (EVAR)

Run by Instituto de Investigacion Sanitaria La Fe · NCT06866769 · Data updated 2026-11-12

This study is testing if using a special ultrasound and blood tests can help monitor patients with repaired abdominal aortic aneurysms more safely than the usual CT scans.

More Abdominal Aortic Aneurysm Without Rupture trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorInstituto de Investigacion Sanitaria La Fe
Academic / other
Drugs / interventionsradiation
Locations1 site (Valencia, Valencia)
StatusRecruiting
StartedJuly 25, 2024
Main results expectedJuly 30, 2025
Study endsApril 30, 2028
Registry record updatedMarch 10, 2025
Trial IDNCT06866769 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients with abdominal aortic aneurysms who are scheduled to undergo EVAR and can provide informed consent.

Probably not a fit

Patients with inflammatory abdominal aortic aneurysms or those with ruptured aneurysms may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study assesses the effectiveness of contrast-enhanced ultrasound (CEUS) and biomarker analysis in monitoring patients with abdominal aortic aneurysm (AAA) who have undergone Endovascular Aneurysm Repair (EVAR). The study aims to compare these methods with the standard computed tomography angiography (CTA), which involves radiation exposure and nephrotoxic contrast agents. By measuring biomarkers and performing CEUS at various intervals, the researchers hope to establish a safer follow-up protocol that minimizes risks associated with traditional imaging techniques. The study will validate the concordance and effectiveness of CEUS and biomarkers in detecting complications such as endoleaks and aneurysm remodeling.

Why it matters

Potential benefit: If successful, this study could provide a safer and more effective follow-up method for patients with AAA, reducing their exposure to harmful radiation and contrast agents.

How similar studies have gone: Previous studies have shown promising results with CEUS and biomarkers in similar contexts, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients with AAA under follow-up who are going to be treated with EVAR.
* signed informed consent to perform CTA, CEUS and for the determination of biomarkers.

Exclusion Criteria:

* patients with inflammatory abdominal aortic aneurysms or ruptured aneurysm.

Where it's running

  • Hospital La Fe
    Valencia, Valencia, Spain
    Recruiting

Study contacts

  • Principal investigator: Juan Manuel Sanchís García — Hospital Universitario La Fe
  • Study coordinator: Juan Manuel Sanchís García
  • Email: sanchis_juagar@gva.es
  • Phone: +34 961245655

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.